|
Christen L. Shoesmith, MD, BSc, FÂé¶¹´«Ã½Ó³»
(University Hospital)
|
The institution of Dr. Shoesmith has received research support from AL-Pharma. The institution of Dr. Shoesmith has received research support from Mitsubishi Tanabe. The institution of Dr. Shoesmith has received research support from Cytokinetics. The institution of Dr. Shoesmith has received research support from Sanofi. The institution of Dr. Shoesmith has received research support from Neurosense. The institution of Dr. Shoesmith has received research support from Regeneron. Dr. Shoesmith has a non-compensated relationship as a Canadian ALS Research Consortium Chair with ALS Canada that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |
|
Michael W. Nicolle, MD
|
Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion, Argenx, Amgen, UCB, Kye, J&J. Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicolle has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various legal firms. |